Background: Papillary thyroid carcinoma (PTC) is the most common histological type of thyroid cancer. Fortunately, most PTC patients have favorable outcomes, but about 20% of patients,however, have distant metastases. Therefore, the exploration of new biomarkers to know new characteristics of PTC should be updated.
The aim of our study is to evaluate the possible role of Dynamin-2 and Angiopoietin-like protein 2 (Anglp2) as novel prognostic markers for papillary thyroid carcinoma.
Material and Methods: In our study, we investigated the expression of DNM2 and Anglp2 in 60 cases of PTC . The clinical significance of the markers was evaluated by assessing correlation with the clinicopathological parameters.
Results: High expression levels of both DNM2 and Anglp2 in PTC were significantly associated with advanced tumor stage, lymph node metastasis, bilaterality, multifocal lesion, extrathyroid involvements , recurrence and death.
Conclusions: DNM2 and Anglp2 were independent PTC markers indicating more likely recurrence and poor prognosis. Expression may help to select the high-risk patients for adjuvant targeted therapy.